IL2 and systemic lupus erythematosus: Anti-T cell receptor (TCR)/CD3 antibodies in sera of SLE patients activate Ca(2+)/calmodulin-dependent kinase IV (CaMKIV) and induce binding of a transcriptional inhibitor of IL-2 gene promoter, resulting in the suppression of IL-2 production [51].